Literature DB >> 23023048

Measuring the blockade of malaria transmission--an analysis of the Standard Membrane Feeding Assay.

Thomas S Churcher1, Andrew M Blagborough, Michael Delves, Chandra Ramakrishnan, Melissa C Kapulu, Andrew R Williams, Sumi Biswas, Dari F Da, Anna Cohuet, Robert E Sinden.   

Abstract

The standard membrane feeding assay (SMFA) is currently considered to be the 'gold standard' for assessing the effectiveness of malaria transmission blocking interventions (TBIs) in vivo. The operation and analysis of SMFAs has varied between laboratories: field scientists often measure TBI efficacy as a reduction in the prevalence of infected mosquitoes whilst laboratory scientists are more likely to quote efficacy as a change in the number of oocysts within the mosquito. These metrics give outputs that differ widely, resulting in a need for greater understanding of how the SMFA informs TBI assessment. Using data from 536 different assays (conducted on Plasmodium falciparum and Plasmodium berghei, in either Anopheles gambiae or Anopheles stephensi) it is shown that the relationship between these metrics is complex, yet predictable. Results demonstrate that the distribution of oocysts between mosquitoes is highly aggregated, making efficacy estimates based on reductions in intensity highly uncertain. Analysis of 30 SMFAs carried out on the same TBI confirms that the observed reduction in prevalence depends upon the parasite exposure (as measured by oocyst intensity in the control group), with assays which have lower exposure appearing more effective. By contrast, if efficacy is estimated as a reduction in oocyst intensity, then this candidate demonstrated constant efficacy, irrespective of the exposure level. To report transmission-blockade efficacy accurately, the results of SMFAs should give both the prevalence and intensity of oocysts in both the control and intervention group. Candidates should be assessed against a range of parasite exposures to allow laboratory results to be extrapolated to different field situations. Currently, many studies assessing TBIs are underpowered and uncertainties in efficacy estimates rarely reported. Statistical techniques that account for oocyst over-dispersion can reduce the number of mosquitoes that need to be dissected and allow TBI candidates from different laboratories to be accurately compared.
Copyright © 2012 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23023048     DOI: 10.1016/j.ijpara.2012.09.002

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  85 in total

Review 1.  Susceptibility Testing of Medically Important Parasites.

Authors:  Abebe Genetu Bayih; Anjan Debnath; Edward Mitre; Christopher D Huston; Benoît Laleu; Didier Leroy; Benjamin Blasco; Brice Campo; Timothy N C Wells; Paul A Willis; Peter Sjö; Wesley C Van Voorhis; Dylan R Pillai
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.

Authors:  Issaka Sagara; Sara A Healy; Mahamadoun H Assadou; Erin E Gabriel; Mamady Kone; Kourane Sissoko; Intimbeye Tembine; Merepen A Guindo; M'Bouye Doucoure; Karamoko Niaré; Amagana Dolo; Kelly M Rausch; David L Narum; David L Jones; Nicholas J MacDonald; Daming Zhu; Rathy Mohan; Olga Muratova; Ibrahima Baber; Mamadou B Coulibaly; Michael P Fay; Charles Anderson; Yimin Wu; Sekou F Traore; Ogobara K Doumbo; Patrick E Duffy
Journal:  Lancet Infect Dis       Date:  2018-07-27       Impact factor: 25.071

3.  Infectiousness of the human population to Anopheles arabiensis by direct skin feeding in an area hypoendemic for malaria in Senegal.

Authors:  Abdoulaye Gaye; Teun Bousema; Gadiaga Libasse; Mamadou O Ndiath; Lassana Konaté; Musa Jawara; Ousmane Faye; Cheikh Sokhna
Journal:  Am J Trop Med Hyg       Date:  2015-01-26       Impact factor: 2.345

Review 4.  When Is a Plasmodium-Infected Mosquito an Infectious Mosquito?

Authors:  Wouter Graumans; Ella Jacobs; Teun Bousema; Photini Sinnis
Journal:  Trends Parasitol       Date:  2020-07-01

Review 5.  Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics.

Authors:  Lucy S Tusting; Teun Bousema; David L Smith; Chris Drakeley
Journal:  Adv Parasitol       Date:  2014       Impact factor: 3.870

Review 6.  Antimalarial drug discovery - approaches and progress towards new medicines.

Authors:  Erika L Flannery; Arnab K Chatterjee; Elizabeth A Winzeler
Journal:  Nat Rev Microbiol       Date:  2013-11-11       Impact factor: 60.633

7.  Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate.

Authors:  Yue Qiu; Yan Zhao; Fei Liu; Bo Ye; Zhenjun Zhao; Sataporn Thongpoon; Wanlapa Roobsoong; Jetsumon Sattabongkot; Liwang Cui; Qi Fan; Yaming Cao
Journal:  Vaccine       Date:  2020-02-21       Impact factor: 3.641

8.  Modulation of transmission success of Plasmodium falciparum gametocytes (sexual stages) in various species of Anopheles by erythrocytic asexual stage parasites.

Authors:  Nirbhay Kumar
Journal:  Acta Trop       Date:  2017-08-30       Impact factor: 3.112

Review 9.  Malaria vaccines and human immune responses.

Authors:  Carole A Long; Fidel Zavala
Journal:  Curr Opin Microbiol       Date:  2016-06-02       Impact factor: 7.934

10.  Anti-Pfs25 human plasma reduces transmission of Plasmodium falciparum isolates that have diverse genetic backgrounds.

Authors:  Dari F Da; Saurabh Dixit; Jetsumon Sattabonkot; Jianbing Mu; Luc Abate; Bhanumati Ramineni; Jean Bosco Ouedraogo; Nicholas J MacDonald; Michael P Fay; Xin-zhuan Su; Anna Cohuet; Yimin Wu
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.